308 related articles for article (PubMed ID: 17521711)
1. Evaluation of reticulated platelets in patients with sickle cell diseases.
Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
[TBL] [Abstract][Full Text] [Related]
2. Platelet P-selectin expression in patients with sickle cell disease who undergo apheresis.
Boga C; Ozdogu H; Kozanoglu I; Sozer O; Sezgin N; Kizilkilic E; Bakar C
Ther Apher Dial; 2007 Aug; 11(4):255-61. PubMed ID: 17661830
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
4. Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Mohan JS; Lip GY; Bareford D; Blann AD
Thromb Res; 2006; 117(6):623-9. PubMed ID: 16051315
[TBL] [Abstract][Full Text] [Related]
5. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
6. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
[TBL] [Abstract][Full Text] [Related]
7. [The relativity study of thrombopoietin and chronic idiopathic thrombocytopenic purpura].
Liao X; Wang Y; Deng C
Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):473-5. PubMed ID: 11758228
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.
Keikhaei B; Mohseni AR; Norouzirad R; Alinejadi M; Ghanbari S; Shiravi F; Solgi G
Eur Cytokine Netw; 2013 Mar; 24(1):45-52. PubMed ID: 23608554
[TBL] [Abstract][Full Text] [Related]
9. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.
Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H
Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411
[TBL] [Abstract][Full Text] [Related]
10. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration.
Panasiuk A; Prokopowicz D; Zak J; Panasiuk B
Hepatogastroenterology; 2004; 51(58):1124-8. PubMed ID: 15239259
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia.
Kurata Y; Hayashi S; Kiyoi T; Kosugi S; Kashiwagi H; Honda S; Tomiyama Y
Am J Clin Pathol; 2001 May; 115(5):656-64. PubMed ID: 11345828
[TBL] [Abstract][Full Text] [Related]
12. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis.
Al-Subaie AM; Fawaz NA; Mahdi N; Al-Absi IK; Al-Ola K; Ameen G; Almawi WY
Eur J Haematol; 2009 Dec; 83(6):579-85. PubMed ID: 19702628
[TBL] [Abstract][Full Text] [Related]
13. [Does menopause affect thrombocytopoiesis and platelet activation?].
Butkiewicz AM; Kemona H; Dymicka-Piekarska V; Matowicka-Karna J
Przegl Lek; 2006; 63(12):1291-3. PubMed ID: 17642142
[TBL] [Abstract][Full Text] [Related]
14. Does smoking affect thrombocytopoiesis and platelet activation in women and men?
Butkiewicz AM; Kemona-Chetnik I; Dymicka-Piekarska V; Matowicka-Karna J; Kemona H; Radziwon P
Adv Med Sci; 2006; 51():123-6. PubMed ID: 17357291
[TBL] [Abstract][Full Text] [Related]
15. Effects of endotoxemia on thrombopoiesis in men.
Stohlawetz P; Folman CC; von dem Borne AE; Pernerstorfer T; Eichler HG; Panzer S; Jilma B
Thromb Haemost; 1999 Apr; 81(4):613-7. PubMed ID: 10235449
[TBL] [Abstract][Full Text] [Related]
16. Duffy phenotype does not influence the clinical severity of sickle cell disease.
Schnog JB; Keli SO; Pieters RA; Rojer RA; Duits AJ
Clin Immunol; 2000 Sep; 96(3):264-8. PubMed ID: 10964545
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
18. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
Al Najjar S; Adam S; Ahmed N; Qari M
Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin oxygen saturation discrepancy using various methods in patients with sickle cell vaso-occlusive painful crisis.
Ahmed S; Siddiqui AK; Sison CP; Shahid RK; Mattana J
Eur J Haematol; 2005 Apr; 74(4):309-14. PubMed ID: 15777343
[TBL] [Abstract][Full Text] [Related]
20. The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients.
Enosolease ME; Ejele OA; Awodu OA
Niger Postgrad Med J; 2005 Jun; 12(2):102-5. PubMed ID: 15997258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
